Acorah Software Products - Accounts Production16.5.460truetruefalsetrueNo description of principal activity12 February 202428 February 202528 February 202515484438Mrs B F Rossouwiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure154844382024-02-11154844382025-02-28154844382024-02-122025-02-2815484438frs-bus:PrivateLimitedCompanyLtd2024-02-122025-02-2815484438frs-bus:FilletedAccounts2024-02-122025-02-2815484438frs-bus:Micro-entities2024-02-122025-02-2815484438frs-bus:EntityHasNeverTraded2024-02-122025-02-2815484438frs-bus:AuditExempt-NoAccountantsReport2024-02-122025-02-2815484438frs-bus:Director12024-02-122025-02-28
Registered number: 15484438
Decode-Your-Genes Ltd
Dormant Financial Statements
For the Period 12 February 2024 to 28 February 2025
Affinity Associates (AU) Limited
Suite A, First Floor, Unit 1
Eurogate Business Park, Trinity Road
Ashford
Kent
TN24 8XW
Decode-Your-Genes Ltd
Statement of Financial Position
As At 28 February 2025
Statement of Financial Position
Registered number: 15484438
28 February 2025
£
Current assets
2
NET CURRENT ASSETS
2
TOTAL ASSETS LESS CURRENT LIABILITIES
2
NET ASSETS
2
CAPITAL AND RESERVES
2
Notes
1.General Information
Decode-Your-Genes Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15484438. The registered office is 64 Hadley Road, Barnet, Hertfordshire, EN5 5QS.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors on 15 October 2025 and were signed on its behalf by: